Zileuton - AbbVie/Chiesi USA
At a glance
- Drug Originator Abbott Laboratories
- Drug Licenced by Chiesi USA; Mylan Specialty; Vectura
- Drug Class Antiasthmatics; Skin disorder therapies; Small molecules; Urea compounds
- Mechanism of Action 5-lipoxygenase inhibitors
- USA Patent Applicants CHIESI
- USA Patents 3
- NDAs 2
Table of Contents
Disclaimer